Relevant bibliographies by topics / Coronary heart disease – Prevention

Contents

  1. Journal articles
  2. Dissertations / Theses
  3. Books
  4. Book chapters
  5. Conference papers
  6. Reports

Academic literature on the topic 'Coronary heart disease – Prevention'

Author: Grafiati
Published: 4 June 2021
Last updated: 30 January 2023

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Coronary heart disease – Prevention.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Coronary heart disease – Prevention"

1

Shakhnoza, Iskandarova, and Amilova Asalya. "PREVENTION OF CORONARY HEART DISEASE." American Journal of Medical Sciences and Pharmaceutical Research 04, no. 04 (April 1, 2022): 19–21. http://dx.doi.org/10.37547/tajmspr/volume04issue04-05.

Full text
Abstract:
Primary prevention, based on healthy lifestyle habits that prevent the emergence of risk factors, is the preferred method of reducing cardiovascular risk. Reducing the prevalence of obesity is the most urgent task, and it is pleiotropic in that it affects blood pressure, lipid profile, glucose metabolism, inflammation, progression of atherothrombotic disease. Physical activity also improves several risk factors, with the added potential to lower heart rate.
APA, Harvard, Vancouver, ISO, and other styles
2

King, Kathryn M., and Heather M. Arthur. "Coronary Heart Disease Prevention." Journal of Cardiovascular Nursing 18, no. 4 (September 2003): 274–81. http://dx.doi.org/10.1097/00005082-200309000-00006.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Rose, Geoffrey, M. P. H. Doublet Stewart, ChristopherA Birt, PeterR Croft, and PatrickF James. "CORONARY HEART DISEASE PREVENTION." Lancet 332, no. 8619 (November 1988): 1081–82. http://dx.doi.org/10.1016/s0140-6736(88)90102-x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Mccormick, JamesS, Petr Skrabanek, J. A. Lee, and R. C. Cottrell. "CORONARY HEART DISEASE PREVENTION." Lancet 332, no. 8621 (November 1988): 1189–90. http://dx.doi.org/10.1016/s0140-6736(88)90252-8.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Linden, B. "Coronary heart disease prevention." Coronary Health Care 3, no. 2 (May 1999): 99–104. http://dx.doi.org/10.1016/s1362-3265(99)80022-4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Linden, Belinda. "Coronary heart disease prevention." Coronary Health Care 3, no. 1 (February 1999): 48–53. http://dx.doi.org/10.1016/s1362-3265(99)80034-0.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Hulse, Iris M. "Prevention of Coronary Heart Disease." Journal of the Royal Society of Medicine 83, no. 10 (October 1990): 672. http://dx.doi.org/10.1177/014107689008301042.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Brooks, Gary. "Prevention of Coronary Heart Disease." Cardiopulmonary Physical Therapy Journal 4, no. 2 (1993): 17. http://dx.doi.org/10.1097/01823246-199304020-00005.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Robin, Eugene D., and Robert K. McCauley. "Prevention of Coronary Heart Disease." Critical Care Medicine 23, no. 9 (September 1995): 1614–15. http://dx.doi.org/10.1097/00003246-199509000-00036.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Hansson, Lennart, Giuseppe Mancia, and Alberto Zanchetti. "Prevention of coronary heart disease." Journal of Hypertension 13, no. 2 (February 1995): 161???162. http://dx.doi.org/10.1097/00004872-199502000-00002.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Coronary heart disease – Prevention"

1

Leong, Yuk-yan Pauline, and 梁玉恩. "The effectiveness of exercise-based cardiac rehabilitation program for secondary prevention of coronary heart disease : a systematic review." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2013. http://hdl.handle.net/10722/193828.

Full text
Abstract:
Objective: To examine the effect of exercise-based cardiac rehabilitation program for secondary prevention of coronary heart disease on cardiac-related mortality, recurrent cardiovascular event and quality of life. Methods: All studies published between 1990 and 2013 in PubMed, and from 1980 to 2013 in EMBASE, which evaluated the effectiveness of exercise-based cardiac rehabilitation program for coronary heart disease. Using the specific keywords “Cardiac rehabilitation”, “Coronary heart disease” OR “Ischemic heart disease” [MeSH], “Exercise” OR “Physical activities” AND “Quality of life” OR “Mortality” AND Cardiovascular events” were searched. A total of 7randomized controlled trials out of 5,051articles from PubMed and 117 articles from EMBASE were included in this systematic review. The primary outcome measures used in the included seven studies were HRQOL, restenosis, cardiac event, cardiac related mortality. Similar demographic and clinical characteristics of the subjects between the intervention and the control groups were recorded. The studies were from five countries. The average age of the subjects in the seven studies was 61years, the average half of them have history of myocardial infarction. Though there were discrepancies among the results generated in the included studies, the potential benefits of exercise-based cardiac rehabilitation could be seen. Results: Compared with the non-exercise-based cardiac rehabilitation, patients allocated to the exercise-based cardiac rehabilitation program had greater improvement in HRQOL and reduction of cardiac events. The result of reducing restenosis was inconsistent. The cardiac related mortality is not significant difference between exercise-based and non-exercise-based cardiac rehabilitation.
published_or_final_version
Public Health
Master
Master of Public Health
APA, Harvard, Vancouver, ISO, and other styles
2

Shaw, I., BS Shaw, and GA Brown. "Influence of strength training on cardiac risk prevention in individuals without cardiovascular disease." African Journal for Physical, Health Education, Recreation and Dance, 2009. http://encore.tut.ac.za/iii/cpro/DigitalItemViewPage.external?sp=1001650.

Full text
Abstract:
Abstract It has widely been shown that exercise, particularly aerobic exercise, has extensive cardioprotective benefits and is an important tool in the prevention of coronary heart disease (CHD). The present investigation aimed to determine the multivariate impact of strength training, designed to prevent the development of CHD, on the Framingham Risk Assessment (FRA) score. Twenty-eight healthy untrained men with low CHD risk (mean age 28 years and 7 months) participated in an eight-week (3- d/wk) strength training programme. Self-administered smoking records, resting blood pressures, total cholesterol (TC), high-density lipoprotein cholesterol (HDLC), FRA scores and absolute 10-year risks for CHD were determined at the pre-test and post-test. After the eight-week period, no significant (p > 0.05) differences were found in number of cigarettes smoked daily, systolic blood pressure, TC, HDLC, FRA scores and absolute 10-year risks for CHD in both the strength-trained (n = 13) and non-exercising control (n = 15) groups. The data indicate that strength training did not reduce the risk of developing CHD and absolute 10-year risk for CHD as assessed by the FRA score.
APA, Harvard, Vancouver, ISO, and other styles
3

Ashton, Emma Louise, and emma ashton@deakin edu au. "Effects of dietary constituents on coronary heart disease risk factors." Deakin University. School of Biological and Chemical Sciences, 2000. http://tux.lib.deakin.edu.au./adt-VDU/public/adt-VDU20061207.153511.

Full text
Abstract:
Coronary Heart Disease (CHD) is a major cause of death in Western countries. Mediterranean and Asian populations have a lower risk of death from CHD compared to Westernised population, as do vegetarian versus omnivorous populations. Dietary constituents of traditional diets consumed by these populations are thought to influence both the classical risk factors for CHD, and the more recently identified risk factors, such as oxidative modification of low density lipoprotein (LDL), LDL particle size, arterial compliance and haemostatic factors. The aim of this thesis was to examine the effects of several food components, particularly soybean and monounsaturated fat (MUFA), on CHD risk factors through 3 carefully controlled dietary interventions, and a cross-sectional study. A randomised crossover dietary intervention study was conducted in 42 healthy males to investigate the effect on CHD risk factors of replacing lean meat with tofu, a soybean product regularly consumed by Asian populations, while controlling all other dietary factors. The tofu diet resulted in significantly lower total cholesterol and triacylglycerol levels compared to the lean meat diet, and LDL particles that were more resistant to in vitro oxidative modification. However, insulin, fibrinogen, factor VII, and lipoprotein (a) were not significantly different on the 2 diets. A postprandial study was subsequently conducted to investigate any acute effects of a tofu test meal on the oxidative modification of LDL in 16 male subjects. There was no significant difference between the susceptibility of LDL to oxidative modification before and after the tofu meal. Twenty eight healthy subjects completed a separate randomised crossover dietary intervention comparing a high MUFA fat diet, using an Australian high oleic sunflower oil, with a low fat, high carbohydrate diet on CHD risk factors. The high MUFA oil diet significantly increased high density lipoprotein cholesterol compared to the low fat diet as well as producing LDL that were more resistant to oxidative modification. Neither the size of the LDL particle nor arterial compliance were significantly different on the 2 diets. Twelve matched pairs of vegetations and omnivores were also studies to compare the habitual diet of a low and higher risk population group, to compare their risk factors and identify dietary constituents that may explain the differences. The vegetarians consumed less saturated fat (SFA) and dietary cholesterol while consuming more polyunsaturated fat, dietary fibre and vitamin E compared to omnivores. The vegetarians had lower total cholesterol, LDL cholesterol and triacylglycerol levels compared to the omnivores and had LDL particles that were more resistant to in vitro oxidation. These findings contribute to our knowledge about the dietary constituents that can alter some CHD risk factors in healthy subjects, and which could reduce the risk of developing CHD. Investigations in high risk groups might reveal even more benefits.
APA, Harvard, Vancouver, ISO, and other styles
4

Wrigley, Martha J. "Engaging families with a premature family history of heart disease : a primary prevention study for coronary heart disease." Thesis, University of Southampton, 2008. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.485524.

Full text
Abstract:
This thesis focuses upon a preventative approach for people with a familial history of premature coronary heart disease. The research study had two aims; firstIy to understand the experience of individuals when their parent or sibling had been diagnosed with heart disease; secondly to develop and evaluate a primary prevention health promotion programme for these people. The thesis provides unique insight into their personal experiences of living with tIris familial diagnosis and gives details of how this population can be identified and involved successfully in a health promotion programme. The study was conducted in a district general hospital; 28 people were recruited of whom 20 participants completed the two year study. Narrative interviews were conducted at the beginning and end of the study, providing insight into people's personal experience. Salutogenesis is the theoretical framework in which the narratives are discussed; from these health resources are identified which can enhance people's progress and maintenance for a healthy lifestyle. The health promotion programme has established, developed and evaluated a nurseled and doctor supported primary pjevention strategy. Education and support was provided in the programme for individuals and families. The participants' physical and behavioural changes were reviewed six monthly, for two years. People are aware of risk factors associated with heart disease, but still seek professional support and advice in relation to their own lifestyle and behaviour. Individual lifestyle changes were achieved by most participants, which translated into significant findings for blood pressure and alcohol consumption; positive changes were seen in physical activity, smoking, diet and psychosocial stress. There were no improvements in lipid profiles. The need for a preventatiye approach in health care, which includes primordial and primary prevention for heart disease, is discussed. The issues in this thesis are reflective upon current government focus to develop preventative health services which actively engage with people as integral to this process. The thesis discusses coronary heart disease, the roles of prevention and health promotion, and identifies health resources for people at high-risk of future cardiovascular problems.
APA, Harvard, Vancouver, ISO, and other styles
5

Veroni, Margherita. "The use of pharmacotherapies in the secondary prevention of coronary heart disease." University of Western Australia. School of Population Health, 2006. http://theses.library.uwa.edu.au/adt-WU2006.0029.

Full text
Abstract:
[Truncated abstract] Background: This thesis examines pharmacotherapy use in the secondary prevention of coronary heart disease. It includes antiplatelet agents, beta-blockers, statins and ACE inhibitors, all shown in landmark clinical trials and meta-analyses to reduce the risk of cardiac events in patients with known coronary disease. Underuse of effective preventive therapies represents a lost opportunity to reduce mortality and morbidity. Overseas studies have shown significant underuse of effective therapies at the time of hospital discharge following an acute event and later in ambulatory care. Australian data on prescribing practices following an acute coronary event and, ongoing use in ambulatory care are sparse. Aims: The aim of this thesis was to quantify the prescription of known effective therapies at the time of hospital discharge following an acute coronary event and ongoing use in ambulatory care. A secondary aim was to identify barriers to optimal secondary prevention thus providing an evidential basis to recommend change. Methods: This was an observational study of a cohort of post-MI patients admitted to a tertiary and affiliate hospital in Perth, Western Australia. The continuum of care from the treatment plan at discharge through to the treatment regimen and risk factor management 12 months post-MI was examined. The intermediate step, communication about the treatment plan with the patient and the primary health care provider was also examined. The study involved a review of hospital medical records and follow-up questionnaires to patients and their general practitioners at 3 and 12 months post-MI. All post-myocardial patients were included in the analysis of prescriptions at discharge. The follow-up study included patients 80 years and younger with no terminal conditions. Patient interviews at 3 months and interviews and focus groups with key hospital staff provided qualitative data to inform the quantitative data.
APA, Harvard, Vancouver, ISO, and other styles
6

Rees, Lois. "The provision of disease prevention services from community pharmacies." Thesis, University College London (University of London), 1994. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.339279.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

裴中 and Zhong Pei. "Neuroprotection of melatonin in ischemic stroke models." Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2002. http://hub.hku.hk/bib/B31243526.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Emberson, Jonathan Robert. "Within-person variation in coronary risk factors : implications for the aetiology and prevention of coronary heart disease." Thesis, University College London (University of London), 2005. http://discovery.ucl.ac.uk/1444402/.

Full text
Abstract:
Epidemiological studies clearly demonstrate the importance of numerous risk factors for coronary heart disease (CHD), including blood lipids, blood pressure, cigarette smoking and physical inactivity. These factors are widely believed to account for only around 50% of CHD cases. However, "within-person" variation in coronary risk factors can affect the size and even direction of estimated aetiological relationships, and though these effects have been explored for the univariate relations of blood pressure and blood cholesterol, much uncertainty remains. In this thesis, data from the British Regional Heart Study, a prospective study of cardiovascular disease in middle-aged British men, is used to investigate the extent and effects of "within-person variation" in a range of coronary risk factors. The effects on estimated relations with CHD are examined and the combined importance of the major risk factors to CHD risk assessed. The potential effectiveness of different CHD prevention strategies, and the size and cause of social inequalities in CHD are also estimated. The findings reveal a high degree of within-person variation in both established and novel coronary risk factors. Taking within-person variation into account, CHD risk-relations for blood lipids, blood pressure, cigarette smoking and physical inactivity increase in magnitude though the estimated protective effect from moderate alcohol intake is reduced. After correction for within-person variation, blood cholesterol, blood pressure and cigarette smoking together account for at least 75 80% of CHD cases in British men. Moderate population-wide improvements in these risk factors could there fore greatly reduce population levels of CHD, while "high-risk" strategies, unless applied to a large proportion of the population, are likely to have only a limited effect. Narrow ing social inequalities in CHD would also have a comparatively modest effect on CHD compared with population-wide control of the key causal coronary risk factors.
APA, Harvard, Vancouver, ISO, and other styles
9

Lalonde, Lyne. "Health-related quality of life measures in coronary heart disease prevention and treatment." Thesis, National Library of Canada = Bibliothèque nationale du Canada, 1998. http://www.collectionscanada.ca/obj/s4/f2/dsk1/tape11/PQDD_0006/NQ44484.pdf.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Khatib, R. "Adherence to secondary prevention medicines by coronary heart disease patients : first reported adherence." Thesis, University of Bradford, 2012. http://hdl.handle.net/10454/5484.

Full text
Abstract:
Background Non-adherence to evidence based secondary prevention medicines (SPM) by coronary heart disease (CHD) patients limits their expected benefits and may result in a lack of improvement or significant deterioration in health. This study explored self-reported non-adherence to SPM, barriers to adherence, and the perception that patients in West Yorkshire have about their medicines in order to inform practice and improve adherence. Methods In this cross-sectional study a specially designed postal survey (The Heart Medicines Survey) assessed medicines-taking behaviour using the Morisky Medicines Adherence 8 items Scale (MMAS-8), a modified version of the Single Question Scale (SQ), the Adherence Estimator (AE), Beliefs about Medicines Questionnaire(BMQ) and additional questions to explore practical barriers to adherence. Patients were also asked to make any additional comments about their medicines-taking experience. A purposive sample of 696 patients with long established CHD and who were on SPM for at least 3 months was surveyed. Ethical approval was granted by the local ethics committee. Results 503 (72%) patients participated in the survey. 52%, 34% and 11% of patients were prescribed at least four, three and two SPMs respectively. The level of non-adherence to collective SPM was 44%. The AE predicted that 39% of those had an element of intentional non-adherence. The contribution of aspirin, statins, clopidogrel, beta blockers, angiotensin converting enzyme inhibitors (ACEI) and angiotensin receptor blockers (ARBs) to overall non-adherence as identified by the SQ scale was 62%, 67%, 7%, 30%, 22% and 5%, respectively. A logistic regression model for overall non-adherence revealed that older age and female gender were associated with less non-adherence (OR = 0.96, 95% CI: 0.94, 0.98; OR = 0.56, 95% CI: 0.34, 0.93; respectively). Specific concern about SPM, having issues with repeat prescriptions and aspirin were associated with more non-adherence (OR = 1.12, 95% CI: 1.07, 1.18; OR = 2.48, 95% CI: 1.26, 4.90, OR = 2.22, 95% CI: 1.18, 4.17). Other variables were associated with intentional and non-intentional non-adherence. 221 (44%) patients elaborated on their medicines-taking behaviour by providing additional comments about the need for patient tailored information and better structured medicines reviews. Conclusions The Medicines Heart Survey was successful in revealing the prevalence of self-reported non-adherence and barriers to adherence in our population. Healthcare professionals should examine specific modifiable barriers to adherence in their population before developing interventions to improve adherence. Conducting frequent structured medicines-reviews, which explore and address patients' concerns about their medicines and healthcare services, and enable them to make suggestions, will better inform practice and may improve adherence.
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "Coronary heart disease – Prevention"

1

Brown, Don. Hyperlipidemia and prevention of coronary heart disease. Seattle, WA: Natural Product Research Consultants, 1997.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

Authority, Northumberland Health. Northumberland coronary heart disease prevention strategy: 1992. Morpeth: Northumberland Health Authority, 1992.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

Royal Colleges of Physicians of the United Kingdom. Committee on Health Promotion. Coronary heart disease prevention: Putting it intopractice. London: Faculty of Public Health Medicine of the Royal Colleges of Physicians of the United Kingdom, 1990.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

Pain, Charles Hawkhurst. Coronary heart disease prevention: An ecological approach. Manchester: University of Manchester, 1990.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

Coronary prevention: A clinical guide. Chicago: Year Book Medical Publishers, 1985.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

Michael, Miller. The practice of coronary disease prevention. Baltimore: Williams & Wilkins, 1996.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

Hofmann, Hubert, ed. Primary and Secondary Prevention of Coronary Heart Disease. Berlin, Heidelberg: Springer Berlin Heidelberg, 1985. http://dx.doi.org/10.1007/978-3-642-70296-9.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Miller, J. M. T. 1944-, ed. 52 ways to prevent heart disease. Nashville: T. Nelson, 1993.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

Tom, Heller, and Open University, eds. Coronary heart disease: Reducing the risk : a reader. Chichester [West Sussex]: Wiley, 1987.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

Calnan, Michael. Preventing coronary heart disease: Prospects, policies and politics. London: Routledge, 1991.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "Coronary heart disease – Prevention"

1

Duprez, Daniel. "Prevention of Coronary Artery Disease." In Coronary Heart Disease, 497–508. Boston, MA: Springer US, 2011. http://dx.doi.org/10.1007/978-1-4614-1475-9_29.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Sherazi, Saadia, and Robert Block. "Coronary Artery Disease Prevention." In Manual of Heart Failure Management, 17–32. London: Springer London, 2009. http://dx.doi.org/10.1007/978-1-84882-185-9_2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Mulcahy, R. "The Role of the General Practitioner in the Prevention of Coronary Heart Disease." In Coronary Heart Disease, 27–57. Dordrecht: Springer Netherlands, 1987. http://dx.doi.org/10.1007/978-94-010-9218-0_2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

de Lorgeril, Michel, and Patricia Salen. "Dietary Prevention of Coronary Heart Disease." In Wild-Type Food in Health Promotion and Disease Prevention, 227–42. Totowa, NJ: Humana Press, 2008. http://dx.doi.org/10.1007/978-1-59745-330-1_17.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Schaefer, Ernst J., and Mariko Tani. "Nutrition and Coronary Heart Disease Prevention." In Dyslipidemias, 329–41. Totowa, NJ: Humana Press, 2015. http://dx.doi.org/10.1007/978-1-60761-424-1_19.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Patel, C. "Prevention Paradox in Coronary Heart Disease." In Biological and Psychological Factors in Cardiovascular Disease, 533–49. Berlin, Heidelberg: Springer Berlin Heidelberg, 1986. http://dx.doi.org/10.1007/978-3-642-71234-0_34.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

von der Lohe, Elisabeth. "Primary and Secondary Prevention of Coronary Heart Disease." In Coronary Heart Disease in Women, 145–74. Berlin, Heidelberg: Springer Berlin Heidelberg, 2003. http://dx.doi.org/10.1007/978-3-642-55553-4_8.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Rose, G. "Social Class and Coronary Heart Disease." In Primary and Secondary Prevention of Coronary Heart Disease, 44–49. Berlin, Heidelberg: Springer Berlin Heidelberg, 1985. http://dx.doi.org/10.1007/978-3-642-70296-9_4.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Puddu, P., and M. Muscari. "Therapy versus prevention of coronary heart disease." In Atherosclerosis and Cardiovascular Diseases, 163–70. Dordrecht: Springer Netherlands, 1987. http://dx.doi.org/10.1007/978-94-009-3205-0_20.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Houston, Mark C. "The Integrative Coronary Heart Disease (CHD) Prevention Program." In The Truth About Heart Disease, 219–76. Boca Raton: CRC Press, 2022. http://dx.doi.org/10.1201/b22808-22.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Coronary heart disease – Prevention"

1

Holm, Jukka, Reijo Laaksonen, Paul Dendale, Cindel Bonneux, and Martijn Scherrenberg. "Creating Audio-Visual Content for a Personalized Prevention Programme in Coronary Heart Disease." In 2022 26th International Conference Information Visualisation (IV). IEEE, 2022. http://dx.doi.org/10.1109/iv56949.2022.00070.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Erzhen, Zen, Lu Yung-Cai, Wang Jain, Shi Fang, Lia Xiaoqing, Zhou Yulin, Jia Xudong, and Gou Zhaozheng. "EXPERIMENTAL STUDIES ON THE MECHANISM OF CHINESE MEDICINAL RHAPONTICUM UNIFLORUM DC IN PREVENTING CORONARY HEART DISEASE." In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1643029.

Full text
Abstract:
The mechanism of Rhaponticum Uniflorum DC in preventing coronary heart disease was studied in vivo and in vitro. TBA fluorescent method was used to determine lipid peroxides (Lpo) and double analysis method was used to determine glutathione peroxidase (GSH-Px) activity and fluorescent polarization of DPH probed membrane fluidity of smooth muscle cell (SMC).Rabbits were fed with high fat diet for 120 days. At the end of experiment, all the animals acquired hyperlipidemia and developed atheroma lesions in aorta and/or coronary. It was found that hyperlipidemia caused a rising of Lpo in blood (from 2.6±0.56 in control up to 8.48±3.28 nmol/ml) and in arterial wall (from 6.75±0.59 in control up to 31.94±4.20 nmol/g protein) and a decreasing of GSH-Px activity in arterial wall (from 0.210±0.095 down to 0.056±0.026 EU/g protein); concomitantly, an increase in microviscosity of arterial SMC membrane (from 1.93±0.04 in control up to 3.49±0.92 poise) which reflects a decrease in fluidity of SMC membrane. Lpo level was higher in plaque area (113.70±46.14 nmol/g protein) than in non-plaque area (58.32±12.69 nmol/g protein). GSH-Px activity level was lower in plaque area (0.0052±0.0014 EU/g protein) than in non-plaque area (0.015+0.0014 EU/g protein). Microviscosity of SMC membrane was higher in plaque area (2.92±0.35 poise) than in non-plaque area (2.26±0.24 poise, p<0.02). By comparison, the rabbits received Rhaponticum Uniflorum DC and VE showed much lowering of Lpo level in arterial wall (down to 10.74±1.61 and 9.93±1.17 nmol/g protein) and decreasing of microviscosity (down to 2.05+0.45 and 2.08+0.50 poise) that is increasing of membrane fluidity of arterial SMC membrane, but GSH-Px activity in arterial wall was keeping at lower level (0.036±0.027 and 0.051±0.027 EU/g protein). The atheroma lesions develped in these two group animals were less severe and fewer in number.
APA, Harvard, Vancouver, ISO, and other styles
3

Mesihović-Dinarević, Senka. "UPDATE IN DIAGNOSTICS CARDIOLOGY." In International Scientific Symposium “Diagnostics in Cardiology and Grown-Up Congenital Heart Disease (GUCH)”. Academy of Sciences and Arts of Bosnia and Herzegovina, 2021. http://dx.doi.org/10.5644/pi2021.199.02.

Full text
Abstract:
Cardiovascular medicine is an area of clinical practice with a continually rapid expansion of knowledge, guidelines, best practices and new technology in adult cardiovascular medicine as well as in paediatric cardiology medicine. Cardiovascular diseases (CVD) are the leading cause of mortality in the world and cause major costs for the health sector and economy. Cardiovascular imaging indices have a significant impact on the prevention, diagnosis, and treatment of cardiac diseases. Advanced imaging technologies have dramatically improved our ability to detect and treat cardiovascular disease at an early stage. Multimodality imaging techniques - echocardiogram, cardiac computerized tomography, magnetic resonance imaging, simulation 3D models, artificial intelligence - are being used more frequently as their utility is better appreciated. Coronavirus disease 2019 (COVID-19) exerts an unprecedented global impact on public health and health care delivery. Severe acute respiratory syndrome coronavirus 2 (SARSCoV-2) causing COVID-19 has reached pandemic levels since March 2020. Patients with cardiovascular (CV) risk factors and established CVD represent a vulnerable population when suffering from COVID-19, and have an increased risk of morbidity and mortality. Severe COVID-19 infection is associated with myocardial damage and cardiac arrhythmia. Diagnostic workup during SARS infection revealed electrocardiographic changes, sub-clinical left ventricular (LV) diastolic impairment and troponin elevation. All professionals in cardiovascular medicine, as a part of lifelong learning process, have the continuous imperative in reviewing novelties, with results data from numerous researches in order to treat all patients according to best practices and evidence-based medicine, especially on this journey through corona pandemic.
APA, Harvard, Vancouver, ISO, and other styles
4

Poniewierski, M., M. Barthels, and H. Poliwoda. "THE SAFETY AND EFFICACY OF A LOW MOLECULAR WEIGHT HEPARIN (FRAGMIN) IN THE PREVENTION OF DEEP VEIN THROMBOSIS IN MEDICAL PATIENTS: A RANDOMIZED DOUBLE-BLIND TRIAL." In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1643224.

Full text
Abstract:
The safety and efficacy of 2500 anti-Factor Xa U of a low molecular weight heparin (Kabi 2165, Fragmin) subcutaneously once a day, and 5000 IU of standard unfractionated Heparin (KabiVitrum, Stockholm) subcutaneously twice daily as thromboprophylaxis was compared in 200 medical patients in a randomized double blind trial. According to the risk of DVT the patients were stratified before randomization in a high and low risk group. The high risk group consisted of 100 patients mainly with malignant diseases and/or previous history of thromboembolism, the low risk group of 100 patients with mainly myocardial infarction and/or coronary heart disease. The prophylaxis was given for seven to ten days. In 192 consecutive patients the clinical status and thermographic screening for DVT (leg temperature profiles, DeVeTherm) were daily evaluated. In two cases of suspected DVT and one case of suspected PE, the following phlebography or pulmonary scintigraphy were found to be negative. In the high risk group, one patient treated with Fragmin having a central venous catheter developed on day 10 symptoms of an arm vein thrombosis. There were no bleeding complications observed in either of the two treatment groups. Two patients with trombocytopenia (25.000 and 22.000/pl) due to chemotherapy and underlying malignant disease were successfully treated with Fragmin without developing any bleeding complications. In eight patients during Fragmin prophylaxis invasive diagnostic methods as heart catheterization, gastroscopy, bronchoscopy or spinal puncture were performed without noticing any bleeding events. 2500 anti-Factor Xa U of Fragmin gave plasma levels by anti-Factor Xa assay (S-2222, Kabi) of mean 0,1 U/ml when blood was sampled three to four hours after the subcutaneus application. There was no accumulation during the treatment periode observed.This study suggests that 2500 anti-Factor Xa U of Fragmin once daily is as safe and effective as 5000 IU of standard heparin twice daily in these medical patients. Especially in patients who need prophylaxis for a long time eg. with malignant disease, the once daily injection is welcomed.
APA, Harvard, Vancouver, ISO, and other styles
5

"Modernising Morbidity and Mortality: Features of Cardiovascular Diseases of the Population of the RSFSR in 1960s." In XII Ural Demographic Forum “Paradigms and models of demographic development”. Institute of Economics of the Ural Branch of the Russian Academy of Sciences, 2021. http://dx.doi.org/10.17059/udf-2021-1-1.

Full text
Abstract:
The article uses archival and published data to study the features of a type of morbidity and mortality of the Russian population observed in the 1960s. The spread of cardiovascular diseases, especially coronary heart disease and atherosclerosis, was noted in the Russian Soviet Federative Socialist Republic (RSFSR). The main reasons for the occurrence of these diseases were considered. Studies conducted in the 1960s showed a high level of disability in patients with such diseases. It was emphasized that cardiovascular diseases gave the highest mortality rates, especially in the urban population. In cities, as well as in the RSFSR as a whole, cardiovascular diseases and mortality from them were common in both men and women (middle-aged and elderly). At the same time, mortality from these diseases was also recorded in groups of young able-bodied people. It was shown that the new type of morbidity and mortality of the population caused the need to focus on health values in the country, improve environmental conditions, transform the work of medical and preventive institutions, and change the lifestyle of the population.
APA, Harvard, Vancouver, ISO, and other styles
6

Kolyaskina, M. M., A. A. Kislyakova, and P. Sh Osmanova. "EMPLOYEES OPERATING AND MAINTAINING WIRED AND WIRELESS COMMUNICATION DEVICES CARDIOVASCULAR RISK DEVELOPMENT MONITORING." In The 4th «OCCUPATION and HEALTH» International Youth Forum (OHIYF-2022). FSBSI «IRIOH», 2022. http://dx.doi.org/10.31089/978-5-6042929-6-9-2022-1-124-127.

Full text
Abstract:
Introduction: Heart disease has been the leading cause of death in the world for the past 20 years. The main pathogenetic mechanism leading to the development of coronary disease and fatal complications is atherosclerosis. The goal of study is to assess cardiovascular risks in workers operating and maintaining communication facilities based on wired and wireless technologies. Materials and methods: 50 employees operating in the field of communications based on wired and wireless technologies health state survey was carried out. Lipid metabolism parameters were assessed, the risks of cardiovascular complications were calculated by SCORE and ASCORE scales, and «Vascular age» was determined. Results: High cardiovascular risk was detected in 40% of examined patients. Elevated values of atherogenic index were already observed in middle-aged people (45-60years). Assessment of SCORE and ASCORE scales revealed a high risk of cardiovascular complications development in middle-aged and elderly people. An excess of vascular age compared to real one in 45-60 years and 61-74 years by an average of 7 (p<0.001) and 5 (p=0.026) years, respectively, was established. Conclusion: The most pronounced changes were found in people of working age (45-60 years). Thus, it is necessary to develop preventive measures aimed to cardio screening with of early signs of health disorders detection, to prevent the development of cardiovascular complications and groups at increased risk of diseases formation.
APA, Harvard, Vancouver, ISO, and other styles
7

Riyaz, Lubna, Muheet Ahmed Butt, and Majid Zaman. "Ensemble Learning for Coronary Heart Disease Prediction." In 2022 International Conference on Intelligent Technologies (CONIT). IEEE, 2022. http://dx.doi.org/10.1109/conit55038.2022.9848292.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Pareek, Vishakha, and R. K. Sharma. "Coronary heart disease detection from voice analysis." In 2016 IEEE Students' Conference on Electrical, Electronics and Computer Science (SCEECS). IEEE, 2016. http://dx.doi.org/10.1109/sceecs.2016.7509344.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Lin, Shisong, Xiaodong Zhuang, Shiyun Huang, Yahui Liu, Linlin Shen, and Xinxue Liao. "Face Analysis for Coronary Heart Disease Diagnosis." In 2019 12th International Congress on Image and Signal Processing, BioMedical Engineering and Informatics (CISP-BMEI). IEEE, 2019. http://dx.doi.org/10.1109/cisp-bmei48845.2019.8966020.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Mangathayaru, Nimmala, B. Padmaja Rani, V. Janaki, Lakshmi Sowmya Kotturi, Manasa Vallabhapurapu, and G. Vikas. "Heart Rate Variability for Predicting Coronary Heart Disease using Photoplethysmography." In 2020 Fourth International Conference on I-SMAC (IoT in Social, Mobile, Analytics and Cloud) (I-SMAC). IEEE, 2020. http://dx.doi.org/10.1109/i-smac49090.2020.9243316.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Coronary heart disease – Prevention"

1

Wei, Dongmei, Yang Sun, and Hankang Hen. Effects of Baduanjin exercise on cardiac rehabilitation after percutaneous coronary intervention: A protocol for systematic review and meta-analysis of randomized controlled trials. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, April 2022. http://dx.doi.org/10.37766/inplasy2022.4.0080.

Full text
Abstract:
Review question / Objective: Can Baduanjin exercise improve the cardiac rehabilitation of patients with coronary artery disease after percutaneous coronary artery surgery? Condition being studied: Coronary heart disease (CHD), also known as coronary artery disease (CAD), is the single most common cause of death globally, with 7.4 million deaths in 2013, accounting for one-third of all deaths (WHO 2014). PCI has been shown to be effective in reducing mortality in patients with CHD. During follow-up, it has been shown that the benefits of PCI can be offset by the significant risks of coronary spasm, endothelial cell injury, recurrent ischemia, and even restenosis or thrombus. Numerous guidelines endorse the necessity for cardiac rehabilitation (CR), which is recommended for patients with chronic stable angina, acute coronary syndrome and for patients following PCI. Baduanjin have been widely practised in China for centuries, and as they are considered to be low risk interventions, their use for the prevention of cardiovascular disease is now becoming more widespread. The ability of Baduanjin to promote clinically meaningful influences in patients with CHD after PCI, however, still remains unclear.
APA, Harvard, Vancouver, ISO, and other styles
2

Xie, Bo, Xiaojiao Cui, Hao Wang, Fuqiang Liu, Fang Qin, Jun Zhang, and Xiaoqing Yi. Prevention of contrast-induced acute kidney injury by probucol combined with hydration in patients with coronary heart disease: a systematic review and meta analysis of randomized controlled trials. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, May 2022. http://dx.doi.org/10.37766/inplasy2022.5.0157.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Treadwell, Jonathan R., James T. Reston, Benjamin Rouse, Joann Fontanarosa, Neha Patel, and Nikhil K. Mull. Automated-Entry Patient-Generated Health Data for Chronic Conditions: The Evidence on Health Outcomes. Agency for Healthcare Research and Quality (AHRQ), March 2021. http://dx.doi.org/10.23970/ahrqepctb38.

Full text
Abstract:
Background. Automated-entry consumer devices that collect and transmit patient-generated health data (PGHD) are being evaluated as potential tools to aid in the management of chronic diseases. The need exists to evaluate the evidence regarding consumer PGHD technologies, particularly for devices that have not gone through Food and Drug Administration evaluation. Purpose. To summarize the research related to automated-entry consumer health technologies that provide PGHD for the prevention or management of 11 chronic diseases. Methods. The project scope was determined through discussions with Key Informants. We searched MEDLINE and EMBASE (via EMBASE.com), In-Process MEDLINE and PubMed unique content (via PubMed.gov), and the Cochrane Database of Systematic Reviews for systematic reviews or controlled trials. We also searched ClinicalTrials.gov for ongoing studies. We assessed risk of bias and extracted data on health outcomes, surrogate outcomes, usability, sustainability, cost-effectiveness outcomes (quantifying the tradeoffs between health effects and cost), process outcomes, and other characteristics related to PGHD technologies. For isolated effects on health outcomes, we classified the results in one of four categories: (1) likely no effect, (2) unclear, (3) possible positive effect, or (4) likely positive effect. When we categorized the data as “unclear” based solely on health outcomes, we then examined and classified surrogate outcomes for that particular clinical condition. Findings. We identified 114 unique studies that met inclusion criteria. The largest number of studies addressed patients with hypertension (51 studies) and obesity (43 studies). Eighty-four trials used a single PGHD device, 23 used 2 PGHD devices, and the other 7 used 3 or more PGHD devices. Pedometers, blood pressure (BP) monitors, and scales were commonly used in the same studies. Overall, we found a “possible positive effect” of PGHD interventions on health outcomes for coronary artery disease, heart failure, and asthma. For obesity, we rated the health outcomes as unclear, and the surrogate outcomes (body mass index/weight) as likely no effect. For hypertension, we rated the health outcomes as unclear, and the surrogate outcomes (systolic BP/diastolic BP) as possible positive effect. For cardiac arrhythmias or conduction abnormalities we rated the health outcomes as unclear and the surrogate outcome (time to arrhythmia detection) as likely positive effect. The findings were “unclear” regarding PGHD interventions for diabetes prevention, sleep apnea, stroke, Parkinson’s disease, and chronic obstructive pulmonary disease. Most studies did not report harms related to PGHD interventions; the relatively few harms reported were minor and transient, with event rates usually comparable to harms in the control groups. Few studies reported cost-effectiveness analyses, and only for PGHD interventions for hypertension, coronary artery disease, and chronic obstructive pulmonary disease; the findings were variable across different chronic conditions and devices. Patient adherence to PGHD interventions was highly variable across studies, but patient acceptance/satisfaction and usability was generally fair to good. However, device engineers independently evaluated consumer wearable and handheld BP monitors and considered the user experience to be poor, while their assessment of smartphone-based electrocardiogram monitors found the user experience to be good. Student volunteers involved in device usability testing of the Weight Watchers Online app found it well-designed and relatively easy to use. Implications. Multiple randomized controlled trials (RCTs) have evaluated some PGHD technologies (e.g., pedometers, scales, BP monitors), particularly for obesity and hypertension, but health outcomes were generally underreported. We found evidence suggesting a possible positive effect of PGHD interventions on health outcomes for four chronic conditions. Lack of reporting of health outcomes and insufficient statistical power to assess these outcomes were the main reasons for “unclear” ratings. The majority of studies on PGHD technologies still focus on non-health-related outcomes. Future RCTs should focus on measurement of health outcomes. Furthermore, future RCTs should be designed to isolate the effect of the PGHD intervention from other components in a multicomponent intervention.
APA, Harvard, Vancouver, ISO, and other styles
4

Dong, Guoqi, Mengye Lu, Xiaoliang Wu, Hao Chen, Hongru Zhang, and Yihuang Gu. Network meta-analysis of Traditional Chinese medicines for depression in coronary heart disease patients. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, May 2020. http://dx.doi.org/10.37766/inplasy2020.5.0036.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Wienke, Andreas, Anne M. Herskind, Kaare Christensen, Axel Skytthe, and Anatoli I. Yashin. The influence of smoking and BMI on heritability in susceptibility to coronary heart disease. Rostock: Max Planck Institute for Demographic Research, January 2002. http://dx.doi.org/10.4054/mpidr-wp-2002-003.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Cai, Ruping, Yuli Xu, and Qiang Su. Meta-analysis of blood lipid reduction for patients with coronary heart disease by combination of pitavastatin and ezetimibe. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, May 2021. http://dx.doi.org/10.37766/inplasy2021.5.0072.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Ghambaryan, Anna. Heart Rate Variability, Catecholamine and Hemodynamic Responses During Rest and Stress in Coronary Artery Disease Patients: The PIMI Study. Fort Belvoir, VA: Defense Technical Information Center, January 2007. http://dx.doi.org/10.21236/ad1013978.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Pan, JianLue, Pangning Huang, Yuanwen Zhang, RongFa Huang, QiuCen Chen, and HuiBing Chen. Commonly Traditional Chinese Medicine in treatment of Coronary Atherosclerotic Heart Disease with Anxiety and Depression: a network meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, April 2021. http://dx.doi.org/10.37766/inplasy2021.4.0124.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Wang, Yali, Yong Liu, Ziqu Zhang, and Yuyun Zhai. Effect of anti-helicobacter pylori treatment on coronary atherosclerotic heart disease: A protocol for systematic review and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, January 2022. http://dx.doi.org/10.37766/inplasy2022.1.0125.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Ma, ZiJun, Jun Chen, KaiQin Jin, and Xin Chen. Efficacy and safety of colchicine in patients with coronary heart disease : a meta-Analysis of randomized controlled clinical trials. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, May 2022. http://dx.doi.org/10.37766/inplasy2022.5.0086.

Full text
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Coronary heart disease – Prevention' for particular source types:
Journal articles Dissertations / Theses Books
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography